TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE

Marc Ehlers, Hidehiro Fukuyama, Tracy L. McGaha, Alan Aderem, Jeffrey V. Ravetch

Research output: Contribution to journalArticle

262 Citations (Scopus)

Abstract

Loss of tolerance in systemic lupus erythematosus (SLE) leads to the generation of autoantibodies, which accumulate in end-organs where they induce disease. Here we show that immunoglobulin (Ig)G2a and 2b autoantibodies are the pathogenic isotypes by recruiting FcγRIV expressing macrophages. Class switching, but not development, of IgM anti-self B cells to these pathogenic subclasses requires the innate immune receptor Toll-like receptor (TLR)9 and MyD88 signaling. In their absence, switching of autoreactive B cells to the IgG2a and 2b subclasses is blocked, resulting in reduced pathology and mortality. In contrast, switching of anti-self B cells to IgG1 is not perturbed and generation of nonautoreactive IgG2a and 2b antibodies is not impaired in TLR9-deficient mice. Thus, the TLR9 pathway is a potential target for therapeutic intervention in SLE. JEM

Original languageEnglish (US)
Pages (from-to)553-561
Number of pages9
JournalJournal of Experimental Medicine
Volume203
Issue number3
DOIs
StatePublished - Mar 20 2006

Fingerprint

Immunoglobulin Class Switching
Systemic Lupus Erythematosus
Autoantibodies
B-Lymphocytes
Toll-Like Receptor 9
Immunoglobulins
Immunoglobulin G
Macrophages
Pathology
Mortality
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. / Ehlers, Marc; Fukuyama, Hidehiro; McGaha, Tracy L.; Aderem, Alan; Ravetch, Jeffrey V.

In: Journal of Experimental Medicine, Vol. 203, No. 3, 20.03.2006, p. 553-561.

Research output: Contribution to journalArticle

Ehlers, Marc ; Fukuyama, Hidehiro ; McGaha, Tracy L. ; Aderem, Alan ; Ravetch, Jeffrey V. / TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. In: Journal of Experimental Medicine. 2006 ; Vol. 203, No. 3. pp. 553-561.
@article{cbbbe7ad7c5d4b80a047757aebaca37a,
title = "TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE",
abstract = "Loss of tolerance in systemic lupus erythematosus (SLE) leads to the generation of autoantibodies, which accumulate in end-organs where they induce disease. Here we show that immunoglobulin (Ig)G2a and 2b autoantibodies are the pathogenic isotypes by recruiting FcγRIV expressing macrophages. Class switching, but not development, of IgM anti-self B cells to these pathogenic subclasses requires the innate immune receptor Toll-like receptor (TLR)9 and MyD88 signaling. In their absence, switching of autoreactive B cells to the IgG2a and 2b subclasses is blocked, resulting in reduced pathology and mortality. In contrast, switching of anti-self B cells to IgG1 is not perturbed and generation of nonautoreactive IgG2a and 2b antibodies is not impaired in TLR9-deficient mice. Thus, the TLR9 pathway is a potential target for therapeutic intervention in SLE. JEM",
author = "Marc Ehlers and Hidehiro Fukuyama and McGaha, {Tracy L.} and Alan Aderem and Ravetch, {Jeffrey V.}",
year = "2006",
month = "3",
day = "20",
doi = "10.1084/jem.20052438",
language = "English (US)",
volume = "203",
pages = "553--561",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE

AU - Ehlers, Marc

AU - Fukuyama, Hidehiro

AU - McGaha, Tracy L.

AU - Aderem, Alan

AU - Ravetch, Jeffrey V.

PY - 2006/3/20

Y1 - 2006/3/20

N2 - Loss of tolerance in systemic lupus erythematosus (SLE) leads to the generation of autoantibodies, which accumulate in end-organs where they induce disease. Here we show that immunoglobulin (Ig)G2a and 2b autoantibodies are the pathogenic isotypes by recruiting FcγRIV expressing macrophages. Class switching, but not development, of IgM anti-self B cells to these pathogenic subclasses requires the innate immune receptor Toll-like receptor (TLR)9 and MyD88 signaling. In their absence, switching of autoreactive B cells to the IgG2a and 2b subclasses is blocked, resulting in reduced pathology and mortality. In contrast, switching of anti-self B cells to IgG1 is not perturbed and generation of nonautoreactive IgG2a and 2b antibodies is not impaired in TLR9-deficient mice. Thus, the TLR9 pathway is a potential target for therapeutic intervention in SLE. JEM

AB - Loss of tolerance in systemic lupus erythematosus (SLE) leads to the generation of autoantibodies, which accumulate in end-organs where they induce disease. Here we show that immunoglobulin (Ig)G2a and 2b autoantibodies are the pathogenic isotypes by recruiting FcγRIV expressing macrophages. Class switching, but not development, of IgM anti-self B cells to these pathogenic subclasses requires the innate immune receptor Toll-like receptor (TLR)9 and MyD88 signaling. In their absence, switching of autoreactive B cells to the IgG2a and 2b subclasses is blocked, resulting in reduced pathology and mortality. In contrast, switching of anti-self B cells to IgG1 is not perturbed and generation of nonautoreactive IgG2a and 2b antibodies is not impaired in TLR9-deficient mice. Thus, the TLR9 pathway is a potential target for therapeutic intervention in SLE. JEM

UR - http://www.scopus.com/inward/record.url?scp=33645076274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645076274&partnerID=8YFLogxK

U2 - 10.1084/jem.20052438

DO - 10.1084/jem.20052438

M3 - Article

C2 - 16492804

AN - SCOPUS:33645076274

VL - 203

SP - 553

EP - 561

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -